Compare topics

12,216
articles
271,613
citations
169
h-index
1902–2026
publication years

Most cited articles

#ArticleYearCitations
1Breast Cancer and Hormonal Contraceptives: Collaborative Reanalysis of Individual Data on 53 297 Women With Breast Cancer and 100 239 Women Without Breast Cancer From 54 Epidemiological Studies19961,301
2Free Cortisol Levels After Awakening: A Reliable Biological Marker for the Assessment of Adrenocortical Activity19971,271
3Combined Oral Contraceptives in Women With Systemic Lupus Erythematosus20051,112
4Risk of Idiopathic Cardiovascular Death and Nonfatal Venous Thromboembolism in Women Using Oral Contraceptives With Differing Progestagen Components.1995700
5Randomised Controlled Trial of Levonorgestrel Versus the Yuzpe Regimen of Combined Oral Contraceptives for Emergency Contraception1998676
6Hormonal Contraception and Risk of Venous Thromboembolism: National Follow-Up Study2009616
7Association of Hormonal Contraception With Depression2016575
8The Venous Thrombotic Risk of Oral Contraceptives, Effects of Oestrogen Dose and Progestogen Type: Results of the MEGA Case-Control Study2009571
9Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs1970522
10Effect of Different Progestagens in Low Oestrogen Oral Contraceptives on Venous Thromboembolic Disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.1995520
11Low Dose Mifepristone and Two Regimens of Levonorgestrel for Emergency Contraception: A WHO Multicentre Randomised Trial2002519
12Liver-Cell Adenomas Associated With Use of Oral Contraceptives1976516
13Oral Contraceptives and the Risk of Venous Thrombosis2001515
14Possible Association Between Benign Hepatomas and Oral Contraceptives.1973511
15Classification and Pharmacology of Progestins2003496
16Ulipristal Acetate Versus Levonorgestrel for Emergency Contraception: A Randomised Non-Inferiority Trial and Meta-Analysis2010476
17Levonorgestrel-Releasing and Copper-Releasing (Nova T) IUDs During Five Years of Use: A Randomized Comparative Trial1994459
18Dissonance and the Pill: An Attribution Approach to Studying the Arousal Properties of Dissonance.1974458
19Cervical Cancer and Hormonal Contraceptives: Collaborative Reanalysis of Individual Data for 16 573 Women With Cervical Cancer and 35 509 Women Without Cervical Cancer From 24 Epidemiological Studies2007450
20Etiology, Management, and Outcome of the Budd-Chiari Syndrome2009448
21Steroid Research at Syntex: “The Pill” and Cortisone1992447
22Women's Trials: The Approval of the First Oral Contraceptive Pill in the United States and Great Britain.2002434
23Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and Progestins1978426
24Oral Contraceptives and Cardiovascular Disease1981420
25Oral Contraceptive Discontinuation: A Prospective Evaluation of Frequency and Reasons1998404
26The Safety of a Drospirenone-Containing Oral Contraceptive: Final Results From the European Active Surveillance Study on Oral Contraceptives Based on 142,475 Women-Years of Observation2007403
27The Effects of Different Formulations of Oral Contraceptive Agents on Lipid and Carbohydrate Metabolism1990400
28Steroids and “the Pill”: Early Steroid Research at Searle1992393
29On the History of Hormonal Contraception I. Ludwig Haberlandt (1885–1932) and His Concept of “Hormonal Sterilization”1970386
30On the History of Hormonal Contraception II. Otfried Otto Fellner (1873-19??) And Estrogens as Antifertility Hormones1971381
31A New Derivative of Triphenylethylene: Effect on Implantation and Mode of Action in Rats.1967380
32Investigation of Relation Between Use of Oral Contraceptives and Thromboembolic Disease.1968372
33Drospirenone: Pharmacology and Pharmacokinetics of a Unique Progestogen2000366
34The Hormonal Activity of the Postmenopausal Ovary.1976364
35Polycystic Ovarian Syndrome (PCOS): Long-Term Metabolic Consequences2018361
36A Single-Center Surgical Experience of 122 Patients With Single and Multiple Hepatocellular Adenomas2009358
37Investigation of Relation Between Use of Oral Contraceptives and Thromboembolic Disease. A Further Report1969354
38Oral Contraceptives and the Risk of Myocardial Infarction2001352
39Biochemical Pharmacology of Antiestrogen Action.1984349
40Third Generation Oral Contraceptives and Risk of Venous Thrombosis: Meta-Analysis2001346
41Ischaemic Stroke and Combined Oral Contraceptives: Results of an International, Multicentre, Case-Control Study1996345
42P450 Enzymes of Estrogen Metabolism1993344
43Progesterone “Block”1956341
44Oral Contraceptives and Venous Thrombosis: Different Sensitivities to Activated Protein C in Women Using Second- and Third-Generation Oral Contraceptives1997341
45Ischemic Stroke Risk With Oral Contraceptives: A Meta-Analysis2000341
46The Effects of Self-Administering Emergency Contraception1998333
47Thromboembolism and Oral Contraceptives: An Epidemiologic Case-Control Study.1969331
48Radioimmunoassay of Serum Progesterone in Women Receiving Oral Contraceptive Steroids1972331
49Myocardial Infarction in Young Women With Special Reference to Oral Contraceptive Practice.1975321
50Contraception Selection, Effectiveness, and Adverse Effects: A Review2021320
51Acute Myocardial Infarction and Combined Oral Contraceptives: Results of an International Multicentre Case-Control Study1997317
52Population-Based Study of Risk of Venous Thromboembolism Associated With Various Oral Contraceptives1997313
53Pharmacological Profile of Progestins2004306
54The Effect of Combined Oral Contraception on Testosterone Levels in Healthy Women: A Systematic Review and Meta-Analysis.2014306
55Mifepristone (RU 486) Compared With High-Dose Estrogen and Progestogen for Emergency Postcoital Contraception1992305
56Cardiovascular Disease and Use of Oral and Injectable Progestogen-Only Contraceptives and Combined Injectable Contraceptives: Results of an International, Multicenter, Case-Control Study1998303
57Stroke in Users of Low-Dose Oral Contraceptives1996302
58Comparison of Ethinylestradiol Pharmacokinetics in Three Hormonal Contraceptive Formulations: The Vaginal Ring, the Transdermal Patch and an Oral Contraceptive2005302
59Use and Misuse of Oral Contraceptives: Risk Indicators for Poor Pill Taking and Discontinuation1995299
60A Prospective Study of the Effects of Oral Contraceptives on Sexuality and Well-Being and Their Relationship to Discontinuation2001297
61Evaluation of Contraceptive Efficacy and Cycle Control of a Transdermal Contraceptive Patch vs an Oral Contraceptive: A Randomized Controlled Trial2001296
62Progestogens and Cardiovascular Reactions Associated With Oral Contraceptives and a Comparison of the Safety of 50- and 30-Microgram Oestrogen Preparations.1980290
63A Gonadotropin-Releasing Hormone Agonist Versus a Low-Dose Oral Contraceptive for Pelvic Pain Associated With Endometriosis1993286
64Can We Identify Women at Risk of Pregnancy Despite Using Emergency Contraception? Data From Randomized Trials of Ulipristal Acetate and Levonorgestrel2011279
65Direct Access to Emergency Contraception Through Pharmacies and Effect on Unintended Pregnancy and STIs: A Randomized Controlled Trial2005278
66The Effects of Oral Contraceptives on Exercise Performance in Women: A Systematic Review and Meta-Analysis2020272
67Continuous Use of an Oral Contraceptive for Endometriosis-Associated Recurrent Dysmenorrhea That Does Not Respond to a Cyclic Pill Regimen2003269
68Oral Contraceptives and Death From Myocardial Infarction.1975268
69Prospective Study of Oral Contraceptives and Hypertension Among Women in the United States1996265
70Association Between the Current Use of Low-Dose Oral Contraceptives and Cardiovascular Arterial Disease: A Meta-Analysis.2005264
71Influence of Oral Contraceptive Therapy on the Activity of Systemic Lupus Erythematosus1982263
72Cancer Risk Among Users of Oral Contraceptives: Cohort Data From the Royal College of General Practitioner's Oral Contraception Study2007259
73Contraceptive Hormone Use and Cardiovascular Disease2009258
74Randomised Comparative Trial of the Intrauterine System and Norethisterone Levonor Gestrel for Treatment of Idiopathic Menorrhagia1998250
75A Prospective Study of Past Use of Oral Contraceptive Agents and Risk of Cardiovascular Diseases1988249
76ACOG Practice Bulletin No. 73: Use of Hormonal Contraception in Women With Coexisting Medical Conditions2006248
77Progestin-Only Contraception and Thromboembolism: A Systematic Review2016248
78A Decade’s Experience With an Individualized Clomiphene Treatment Regimen Including Its Effect on the Postcoital Test1982246
79Clomiphene Citrate: Mechanism(s) and Site(s) of Action—A Hypothesis Revisited1984245
80Proniosome Based Transdermal Delivery of Levonorgestrel for Effective Contraception1998243
81Oral Contraceptives and Thromboembolic Disease: Effects of Lowering Œstrogen Content1980242
82A Multicenter, Randomized Study of an Extended Cycle Oral Contraceptive2003242
83A Prospective Randomized Comparison of Levonorgestrel With the Yuzpe Regimen in Post-Coital Contraception1993241
84Timing of Emergency Contraception With Levonorgestrel or the Yuzpe Regimen1999241
85Ethinylestradiol and Dl-Norgestrel as a Postcoital Contraceptive1977238
86Resistance to Activated Protein C as a Basis for Venous Thromboembolism Associated With Pregnancy and Oral Contraceptives1995237
87History of Oral Contraceptive Drugs and Their Use Worldwide2013236
88Hormone Withdrawal Symptoms in Oral Contraceptive Users2000234
89Plasma Concentrations of Free and Non-TeBG Bound Testosterone in Women on Oral Contraceptives1974233
90Oral Contraceptive Pills as Primary Prevention for Ovarian Cancer: A Systematic Review and Meta-Analysis2013233
91A Prospective Comparison of Bone Density in Adolescent Girls Receiving Depot Medroxyprogesterone Acetate (Depo-Provera), Levonorgestrel (Norplant), or Oral Contraceptives1996232
92Effect of Four Different Oral Contraceptives on Various Sex Hormones and Serum-Binding Globulins2003232
93To What Extent Do Oral Contraceptives Influence Mood and Affect?2002231
94Health During Prolonged Use of Levonorgestrel 20 μg/d and the Copper TCu 380Ag Intrauterine Contraceptive Devices: A Multicenter Study1994230
95The Efficacy of Intrauterine Devices for Emergency Contraception: A Systematic Review of 35 Years of Experience2012230
96Lifetime Cancer Risk and Combined Oral Contraceptives: The Royal College of General Practitioners’ Oral Contraception Study2017230
97Reprint of Classification and Pharmacology of Progestins2008226
98Pharmacokinetics of Etonogestrel and Ethinylestradiol Released From a Combined Contraceptive Vaginal Ring2000225
99Bone Density in Women Receiving Depot Medroxyprogesterone Acetate for Contraception.1991224
100Oral Contraceptives and Stroke in Young Women: Associated Risk Factors1975223